Protective modulation of carotid atherosclerosis in hyperalphalipoproteinemic individuals
F D Santiago1, R T Nakamura, D Kaplan
1Clinical Pathology Department, Medical School, University of Campinas, Campinas, SP, Brazil.
Insights
Individuals with hyperalphalipoproteinemia (Hyper-A) show similar carotid intima-media thickness (cIMT) compared to controls, suggesting high-density lipoprotein cholesterol (HDL-C) offers atheroprotection despite increased cardiovascular risk factors.
Area of Science:
- Cardiovascular Science
- Lipid Metabolism
- Vascular Biology
Background:
- Hyperalphalipoproteinemia (Hyper-A) is characterized by elevated high-density lipoprotein cholesterol (HDL-C).
- The impact of Hyper-A on carotid intima-media thickness (cIMT) and its relationship with cardiovascular risk factors requires further investigation.
Purpose of the Study:
- To investigate whether Hyper-A modifies cIMT.
- To determine if Hyper-A influences the association between clinical/biochemical parameters and cIMT.
Main Methods:
- Study included 169 asymptomatic individuals: 71 with Hyper-A (HDL-C ≥68 mg/dL) and 98 controls.
- Biochemical analyses included lipid profiles, hepatic lipase (HL), lipoprotein lipase (LPL), cholesteryl ester transfer protein (CETP), and phospholipids transfer protein (PLTP) activities.
- Carotid intima-media thickness (cIMT) was assessed using high-resolution B-mode ultrasonography.
Main Results:
- The Hyper-A group was older and exhibited higher frequencies of hypercholesterolemia, hypertension, sedentariness, and postmenopausal status.
- Adjusted mean cIMT was similar between Hyper-A and control groups (0.85 ± 0.24 mm vs. 0.69 ± 0.17 mm).
- In Hyper-A, only age predicted cIMT, whereas in controls, age, male sex, blood pressure, and HDL-C predicted cIMT variations.
Conclusions:
- Despite a higher prevalence of cardiovascular risk factors, Hyper-A individuals had similar cIMT to controls.
- These findings suggest that HDL-C exerts atheroprotective effects, mitigating the risk associated with other factors in Hyper-A.
- Carotid thickness in Hyper-A appears resistant to modulation by metabolic and anthropometric factors, except for age.
Abstract:
To determine whether hyperalphalipoproteinemia modifies carotid intima-media thickness (cIMT) and/or influences the relationship of clinical and biochemical parameters with cIMT. This study was conducted on 169 asymptomatic individuals, classified as hyperalphalipoproteinemic (Hyper-A) (Hyper-A, n = 71, HDL-C > or =68 mg/dL) and controls (CTL) (CTL, n = 98, HDL-C >32 and <68 mg/dL). Enzymatic, nephelometric and ultracentrifugation methods were used for biochemical determinations. Hepatic lipase (HL), lipoprotein lipase (LPL), cholesteryl ester transfer protein (CETP) and phospholipids transfer protein (PLTP) activities were measured by radiometric exogenous methods. The prevalence of dyslipidemia, hypertension, smoking, sedentariness, postmenopausal women, coronary artery disease (CAD) and familial history of CAD were determined. High resolution beta-mode carotid ultrassonography was performed. The Hyper-A group was older and had higher frequencies of hypercholesterolemia (40%), hypertension (31%), sedentariness (37%) and postmenopausal women (1%). In Hyper-A individuals, the mean cIMT after adjustment for age and gender was similar between the groups (0.85 +/- 0.24 mm Hyper-A versus 0.69 +/- 0.17 mm CTL). In multivariate models, age was a significant predictor of cIMT in Hyper-A (R (2) = 0.04, p < or = 0.001), independently of other clinical or biochemical factors. In contrast to CTL, where age (R (2) = 0.63 p < or = 0.001), male sex (R (2) = 0.03, p < or = 0.001), blood pressure (R (2) = 0.006, p < or = 0.001) and HDL-C (R (2) = 0.02, p < 0.022) accounted for the cIMT variations. Despite an increased prevalence of cardiovascular risk factors in Hyper-A and resistance of carotid thickness to modulation by metabolic and anthropometric factors (except age), the similarity in cIMT between Hyper-A and healthy individuals emphasizes the atheroprotective effects of HDL.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis IV: Nursing Management
Coronary Artery Disease I: Introduction

